Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1971 1
1973 1
1975 1
1976 1
1977 1
1979 3
1981 1
1982 2
1983 2
1984 1
1985 3
1987 1
1988 2
1989 2
1991 4
1992 3
1995 2
1997 2
1998 5
1999 5
2000 1
2001 6
2002 4
2003 4
2004 3
2005 5
2006 6
2007 6
2008 4
2009 5
2010 5
2011 4
2012 1
2013 6
2014 5
2015 5
2016 2
2017 3
2018 9
2019 7
2020 2
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

132 results
Results by year
Filters applied: . Clear all
Page 1
Selexipag for the Treatment of Pulmonary Arterial Hypertension.
Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV; GRIPHON Investigators. Sitbon O, et al. Among authors: preiss r. N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184. N Engl J Med. 2015. PMID: 26699168 Free article. Clinical Trial.
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N. McLaughlin VV, et al. Among authors: preiss r. J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010. J Am Coll Cardiol. 2018. PMID: 29447737 Free article. Clinical Trial.
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.
Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galiè N, Ghofrani HA, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Hoeper MM. Gaine S, et al. Among authors: preiss r. Eur Respir J. 2017 Aug 17;50(2):1602493. doi: 10.1183/13993003.02493-2016. Print 2017 Aug. Eur Respir J. 2017. PMID: 28818881 Free PMC article. Clinical Trial.
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON Study.
Gaine S, Sitbon O, Channick RN, Chin KM, Sauter R, Galiè N, Hoeper MM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Tapson V, Ghofrani HA, Lang I. Gaine S, et al. Among authors: preiss r. Chest. 2021 Jul;160(1):277-286. doi: 10.1016/j.chest.2021.01.066. Epub 2021 Feb 3. Chest. 2021. PMID: 33545163 Free article. Clinical Trial.
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study.
Coghlan JG, Channick R, Chin K, Di Scala L, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Gaine S. Coghlan JG, et al. Among authors: preiss r. Am J Cardiovasc Drugs. 2018 Feb;18(1):37-47. doi: 10.1007/s40256-017-0262-z. Am J Cardiovasc Drugs. 2018. PMID: 29307087 Free PMC article. Clinical Trial.
sIL-6R: more than an agonist?
Knüpfer H, Preiss R. Knüpfer H, et al. Among authors: preiss r. Immunol Cell Biol. 2008 Jan;86(1):87-91. doi: 10.1038/sj.icb.7100113. Epub 2007 Aug 28. Immunol Cell Biol. 2008. PMID: 17724457 Review.
Cyclophosphamide and related anticancer drugs.
Baumann F, Preiss R. Baumann F, et al. Among authors: preiss r. J Chromatogr B Biomed Sci Appl. 2001 Nov 25;764(1-2):173-92. doi: 10.1016/s0378-4347(01)00279-1. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11817027 Review.
Significance of interleukin-6 (IL-6) in breast cancer (review).
Knüpfer H, Preiss R. Knüpfer H, et al. Among authors: preiss r. Breast Cancer Res Treat. 2007 Apr;102(2):129-35. doi: 10.1007/s10549-006-9328-3. Epub 2006 Aug 23. Breast Cancer Res Treat. 2007. PMID: 16927176 Review.
132 results